PERCUTANEOUS CORONARY INTERVENTION (PCI)
Clinical trials for PERCUTANEOUS CORONARY INTERVENTION (PCI) explained in plain language.
Never miss a new study
Get alerted when new PERCUTANEOUS CORONARY INTERVENTION (PCI) trials appear
Sign up with your email to follow new studies for PERCUTANEOUS CORONARY INTERVENTION (PCI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Balloon or stent? new study aims to find safer option for heart patients
Disease control Not yet recruitingThis study compares two treatments for coronary artery disease: a drug-coated balloon and a drug-eluting stent. It focuses on patients with high bleeding risk who need a simpler approach. Researchers will track heart attacks, strokes, and bleeding events to see which option is sa…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION (PCI)
Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could 7 days of dual blood thinners be enough for elderly heart patients?
Disease control Not yet recruitingThis study looks at whether older adults (65+) who get a heart stent can safely stop one of their blood thinners (aspirin) after just 7 days instead of the usual 3 to 12 months. The goal is to see if this shorter treatment reduces bleeding risks without increasing heart attacks, …
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION (PCI)
Phase: PHASE3 • Sponsor: Vincent ROULE • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Nearly 10,000 heart attack patients to test ancient pill for better recovery
Disease control Not yet recruitingThis large study will test whether adding Shexiang Baoxin Pill (Muskardia) to standard treatment helps people who have had a heart attack. About 9,588 participants will receive either standard care alone or standard care plus the pill for 12 months. The goal is to see if the pill…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION (PCI)
Phase: PHASE4 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated Jun 26, 2026 13:58 UTC
-
Heart attack recovery: could exercise rebuild your heart?
Disease control Not yet recruitingThis study looks at whether a 12-week cardiac rehabilitation program—including supervised exercise, education, and lifestyle advice—can improve heart function and quality of life in people who have had a heart attack treated with stenting. One hundred participants will be randoml…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION (PCI)
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 26, 2026 13:41 UTC
-
New study to track survival in High-Risk heart procedures
Knowledge-focused Not yet recruitingThis study will follow 1000 adults in China with severe coronary artery disease who are too high-risk for bypass surgery and need complex angioplasty. Researchers will collect data on their health, procedures, and outcomes for one year to see what factors affect survival and comp…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION (PCI)
Sponsor: Guofeng Gao • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Heart drug colchicine may reveal new clues to fight inflammation
Knowledge-focused Not yet recruitingThis study looks at how a low dose of colchicine, an anti-inflammatory drug, changes proteins in the blood of people with coronary heart disease and high inflammation. Researchers will compare protein levels before and after one month of treatment in 176 patients. The goal is to …
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION (PCI)
Phase: PHASE4 • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC